Chronic Obstructive Pulmonary Treatment

Overview Forums Topics Doctor Questions eHealthpedia
Ask our Community
Members
eHealthpedia Articles
Asthma Diagnosis
Who do you see to diagnose asthma? And what diagnostic tests can you expect. Click here to learn how to get a correct asthma diagnosis.
High Blood Pressure Causes and Risk Factors
Hypertension can be caused by a number of underlying medical conditions. Which ones? Are you at risk of developing high blood pressure?
Pneumonia Causes and Risk Factors
Some people are more at risk of getting pneumonia than others. Are you one of them? Learn more about how you get pneumonia and who is at risk here.
Conditions and Diseases Screening
Learn about screening and diagnosis options available for certain conditions and diseases.
More
Topics
rosalif
rosalif / Lungs and Respiratory Disorders
More
Doctor Answers
Dr. Ana Aleksovska
Dr. Ana Aleksovska / Lungs and Respiratory Disorders
More
News
Gene Research, Banned Inhalers Change Asthma, COPD Treatment Options
U.S. researchers are using genetics to explain why some asthma sufferers do not respond well to steroid inhalers, the most common form of asthma treatment. Over-the-counter inhalers that use CFCs have also been banned. Here are some facts about asthma, Ch
Elevation reports positive results for COPD treatment
The successful phase 2 clinical trial results allowed the San Diego drug developer to collect the final $17 million portion of $30 million promised by investors during a fund-raising round in early 2010.
Pearl Therapeutics' Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva®
REDWOOD CITY, Calif., Sept. 26, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. presented additional positive results from its  Phase 2b study (NCT01085045) demonstrating that the dual bronchodilator combination product, PT003 (GFF MDI) provides superior in
COPD Patients Experienced Benefits From the First Dose When Treated With Aclidinium, as Shown in the ATTAIN Phase III ...
AMSTERDAM, September 27, 2011 /PRNewswire/ - Aclidinium Demonstrates Improved Lung Function, Symptom Control and Quality of Life for Chronic Obstructive Pulmonary Disease (COPD) Patients Almirall, S.A. (ALM.MC) today announced results from …
New Novartis data show potential of respiratory portfolio to help COPD patients maintain active and productive lives
Novartis International AG / New Novartis data show potential of respiratory portfolio to help COPD patients maintain active and productive lives . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content …